2023-03-30 2024-03-29 false Capium Accounts Production 1.1 09550457 2023-03-30 2024-03-29 09550457 bus:AbridgedAccounts 2023-03-30 2024-03-29 09550457 bus:Micro-entities 2023-03-30 2024-03-29 09550457 bus:AuditExempt-NoAccountantsReport 2023-03-30 2024-03-29 09550457 bus:SmallCompaniesRegimeForAccounts 2023-03-30 2024-03-29 09550457 bus:PrivateLimitedCompanyLtd 2023-03-30 2024-03-29 09550457 2023-03-30 2024-03-29 09550457 2024-03-29 09550457 bus:RegisteredOffice 2023-03-30 2024-03-29 09550457 core:WithinOneYear 2024-03-29 09550457 core:AfterOneYear 2024-03-29 09550457 1 2023-03-30 2024-03-29 09550457 bus:Director1 2023-03-30 2024-03-29 09550457 bus:Director1 2024-03-29 09550457 bus:Director1 2022-03-30 2023-03-29 09550457 bus:Director2 2023-03-30 2024-03-29 09550457 bus:Director2 2024-03-29 09550457 bus:Director2 2022-03-30 2023-03-29 09550457 bus:Director3 2023-03-30 2024-03-29 09550457 bus:Director3 2024-03-29 09550457 bus:Director3 2022-03-30 2023-03-29 09550457 bus:Director4 2023-03-30 2024-03-29 09550457 bus:Director4 2024-03-29 09550457 bus:Director4 2022-03-30 2023-03-29 09550457 bus:Director5 2023-03-30 2024-03-29 09550457 bus:Director5 2024-03-29 09550457 bus:Director5 2022-03-30 2023-03-29 09550457 bus:Director6 2023-03-30 2024-03-29 09550457 bus:Director6 2024-03-29 09550457 bus:Director6 2022-03-30 2023-03-29 09550457 2022-03-30 09550457 bus:LeadAgentIfApplicable 2023-03-30 2024-03-29 09550457 2022-03-30 2023-03-29 09550457 2023-03-29 09550457 core:WithinOneYear 2023-03-29 09550457 core:AfterOneYear 2023-03-29 09550457 bus:EntityAccountantsOrAuditors 2022-03-30 2023-03-29 09550457 core:ComputerEquipment 2023-03-30 2024-03-29 09550457 core:ComputerEquipment 2024-03-29 09550457 core:ComputerEquipment 2023-03-29 09550457 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-03-29 09550457 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-03-29 09550457 core:CostValuation core:Non-currentFinancialInstruments 2024-03-29 09550457 core:CostValuation core:Non-currentFinancialInstruments 2023-03-29 09550457 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-03-29 09550457 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-03-29 09550457 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-03-29 09550457 core:Non-currentFinancialInstruments 2024-03-29 09550457 core:Non-currentFinancialInstruments 2023-03-29 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 09550457
England and Wales

 

 

 

ESSEX MEDICAL SOCIETY LIMITED


Abridged Accounts
 


Period of accounts

Start date: 30 March 2023

End date: 29 March 2024
  2024   2023
    £ £   £ £
Fixed assets   94      125 
Current assets 6,402      4,666   
Creditors: amount falling due within one year (6,496)     (4,791)  
Net current assets   (94)     (125)
Total assets less current liabilities      
Net assets      
 

         
Capital and reserves      
 
NOTES TO THE ACCOUNTS

General Information
ESSEX MEDICAL SOCIETY LIMITED is a private company, limited by guarantee, registered in England and Wales, registration number 09550457, registration address 118 WICKHAY, BASILDON, ESSEX, SS15 5AQ.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Computer Equipment 25% Reducing Balance
Provisions
Provisions are recognised when the company has a present obligation as a result of a past event which it is more probable than not will result in an outflow of economic benefits that can be reasonably estimated.
2.

Tangible fixed assets

Cost or valuation Computer Equipment   Total
  £   £
At 30 March 2023 700    700 
Additions  
Disposals  
At 29 March 2024 700    700 
Depreciation
At 30 March 2023 575    575 
Charge for year 31    31 
On disposals  
At 29 March 2024 606    606 
Net book values
Closing balance as at 29 March 2024 94    94 
Opening balance as at 30 March 2023 125    125 


3.

Average number of employees

Average number of employees during the year was 0 (2023 : 0).


For the year ended 29 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' Responsibilities:
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts.
The financial statements were approved by the board of directors on 23 December 2024 and were signed on its behalf by:


--------------------------------
Dr Srinivasan Sampathkumar
Director
1